Literature DB >> 7856287

Vaccinoprophylaxis of mumps using mumps vaccine, strain Sofia 6, in Bulgaria.

H Odisseev1, N Gacheva.   

Abstract

A mumps vaccine, using strain Sofia 6 prepared in guinea-pig kidney primary cell cultures, was gradually introduced in Bulgaria to vaccinate 1- to 12-year-old children between 1972 and 1976. It was included in the national vaccine programme in 1977. The vaccine showed a slight reactogenicity, a good immunogenicity and a high epidemiological efficacy. Due to the increased morbidity of mumps, revaccination was carried out in 4- to 12-year-old children in 1982. A high level of side-effects, mainly meningitis, was registered, and led to suspension of the mumps vaccine in Bulgaria.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7856287     DOI: 10.1016/s0264-410x(94)80047-4

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  3 in total

1.  Evaluation of a neonatal rat model for prediction of mumps virus neurovirulence in humans.

Authors:  S A Rubin; M Pletnikov; R Taffs; P J Snoy; D Kobasa; E G Brown; K E Wright; K M Carbone
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

2.  Mumps caused by an inadequately attenuated measles, mumps and rubella vaccine.

Authors:  W Bakker; R Mathias
Journal:  Can J Infect Dis       Date:  2001-05

3.  In vitro and in vivo growth alter the population dynamic and properties of a Jeryl Lynn mumps vaccine.

Authors:  Sarah M Connaughton; Jun X Wheeler; Eva Vitková; Philip Minor; Silke Schepelmann
Journal:  Vaccine       Date:  2015-07-15       Impact factor: 3.641

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.